Enveric Biosciences Inc — Quarterly Financial Statistics (NASDAQ:ENVB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -927.07 K-1.31 M-2.39 M-1.89 M-2.07 M -7.67 M Cash from investing activities 00——— — Cash from financing activities 517.69 K463.45 K4.45 M449.1 K2.99 M 8.35 M Free cash flow -927.07 K-1.31 M-2.39 M-1.89 M-2.07 M -7.67 M

Noticias

Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested - Enveric Biosciences (NASDAQ:ENVB)

Las acciones de Enveric Biosciences se disparan tras revelar nuevos datos sobre su candidato a fármaco principal

Acciones de Enveric Biosciences se disparan tras revelar nuevos datos

Enveric Biosciences stock soars after revealing new data on lead drug candidate

Fármaco principal de Enveric activa vías clave ligadas al alivio de la depresión

Fármaco líder de Enveric activa vías clave ligadas al alivio de depresión

Enveric’s lead drug candidate activates key pathways linked to depression relief

Enveric Advances Lead Drug With New Findings On Key Brain Receptor Signals - Enveric Biosciences (NASDAQ:ENVB)

Enveric Biosciences registra 1,35 millones de dólares en nuevas acciones bajo acuerdo ATM

Enveric Biosciences registra $1.35 millones en nuevas acciones bajo acuerdo ATM

Enveric Biosciences registers $1.35 million in new shares under ATM agreement

Enveric licencia la cartera de marcas RCANN a TOTEC Pharma